← All trials
NCT01637675
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2013
- Primary completion
- Dec 1, 2014
- Completion date
- Dec 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 90
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Guangzhou Medical UniversityLead sponsor
- Guangzhou Medical UniversityReponsible party - principal investigator
- Qingdao UniversityCollaborator
- Capital Medical UniversityCollaborator
- Zhejiang UniversityCollaborator
- Shantou UniversityCollaborator
- Jiangsu Carefree Pharmaceutical Co., Ltd.Collaborator
- Nanjing UniversityCollaborator
- Zhengzhou UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- Jiao Tong UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.